Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Analyst Rating of “Hold”
Shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) received an average rating of “Hold” by the fourteen brokerages that cover the company, reports MarketBeat Ratings. Three equity research analysts rated the stock with a sell recommendation, seven gave the company a hold recommendation and three gave the company a buy recommendation. The 12-month average …
Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Analyst Rating of “Hold” Read More »